Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection

SARS-CoV-2 antibody assays are crucial in managing the COVID-19 pandemic. Approved mRNA COVID-19 vaccines are well known to induce a serum antibody responses against the spike protein and its RBD. Mucosal immunity plays a major role in the fight against COVID-19 directly at the site of virus entry;...

Descrición completa

Detalles Bibliográficos

Principais autores:	Mariapia Guerrieri, Beatrice Francavilla, Denise Fiorelli, Marzia Nuccetelli, Francesco Maria Passali, Luca Coppeta, Giuseppina Somma, Sergio Bernardini, Andrea Magrini, Stefano Di Girolamo
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2021-12-01
Series:	Vaccines
Assuntos:	IgA nasal salivary SARS-CoV-2 vaccine mucosal
Acceso en liña:	https://www.mdpi.com/2076-393X/9/12/1499
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!